TickerFacts.

Verrica Pharmaceuticals Inc. (VRCA): Cost of Revenue

Annual figures by period end, from SEC filings.

$2.60M
Year ended 2024-12-31
2023-12-31: $500.0K2024-12-31: $2.60M$2.60M
2023-12-31 Cost of Revenue (USD) 2024-12-31
Period endedCost of RevenueChange YoYSource filing
2024-12-31$2.60M+420.0%2025-03-11, From 2024-01-01
2023-12-31$500.0Kn/a2025-03-11, From 2023-01-01